Composition

Each co-blister contains: A. 1 uncoated dispersible tablet containing Sulfadoxine 250 mg & Pyrimethamine 12.5 mg B. 3 uncoated dispersible tablets of Amodiaquine (as Hydrochloride) 76.5 mg  

ATC Code/ATCvet Code

P01BA06  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

25 x (3+1)'s (in PVC-Alu blisters)  

Product Description

Dispersible tablets LARIDOX-AQ DT(SULFADOXINE AND PYRIMETHAMINE DISPERSIBLE TABLETS(250MG/12.5MG) AND AMODIAQUINE DISPERSIBLE TABLETS 76.5MG) LARIDOX-AQ DT "(A)SULFADOXINE/PRIMETHAMINE 250MG/12.5MGDISPERSIBLE TABLETS, EXCIPIENTS ARE MICROCRYSTALLINE CELLULOSE, PREGELATINISED STARCH, COLLOIDAL SILICON DIOXIDE, CROPOVIDONE, POVIDONE, SUCRALOSE AND MAGNESIUM STEARATE (B) AMODIAQUINE (AS HYDROCHLORIDE) 76.5MG DISPERSIBLE TABLETS, EXCIPINETS ARE CROSCARMELLOSE SODIUM, MICROCRYSTALLINE CELLULOSE, POVIDONE,SUCRALOSE, SODIUM BICARBONATE,MAGNESIUM STEARATE.IT IS ESSENTIALLY SODIUM-FREE, IT CONTAINS LESS THAN 1 MMOL SODIUM(23MG) PER TABLET. " A4-101235 Drugs Imported Product 25*3+1 14-03-2025 IPCA PHARMA NIGERIA LIMITED, , OSOLO WAY AJAO ESTATE, LAGOS ISOLO LAGOS 08022389727 ipcapharma@yahoo.com "IPCA LABORATORIES LIMITED, PLOT NO 255/1 ATHAL SILVASSA PIN 396230(D&NH) INDIA

Manufacturer Name

IPCA Laboratories Ltd.

Manufacturer Country

INDIA  

Approval Date

2025-04-30  

Expiry Date

2030-04-29